556 related articles for article (PubMed ID: 26416284)
1. Synthesis and Characterization of PLGA Shell Microcapsules Containing Aqueous Cores Prepared by Internal Phase Separation.
Abulateefeh SR; Alkilany AM
AAPS PharmSciTech; 2016 Aug; 17(4):891-7. PubMed ID: 26416284
[TBL] [Abstract][Full Text] [Related]
2. Preparation of Aqueous Core-Poly(d,l-Lactide-co-Glycolide) Shell Microcapsules With Mononuclear Cores by Internal Phase Separation: Optimization of Formulation Parameters.
Abulateefeh SR; Alkawareek MY; Abdullah FR; Alkilany AM
J Pharm Sci; 2017 Apr; 106(4):1136-1142. PubMed ID: 28057545
[TBL] [Abstract][Full Text] [Related]
3. Benign preparation of aqueous core poly lactic-co-glycolic acid (PLGA) microcapsules.
Nomura T; Routh AF
J Colloid Interface Sci; 2018 Mar; 513():1-9. PubMed ID: 29128617
[TBL] [Abstract][Full Text] [Related]
4. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules.
Abulateefeh SR; Alkawareek MY; Alkilany AM
Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178
[TBL] [Abstract][Full Text] [Related]
5. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
6. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
9. Preparation of insulin-loaded PLA/PLGA microcapsules by a novel membrane emulsification method and its release in vitro.
Liu R; Huang SS; Wan YH; Ma GH; Su ZG
Colloids Surf B Biointerfaces; 2006 Aug; 51(1):30-8. PubMed ID: 16814994
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of sustained release microspheres containing oxymatrine and their release characteristics in vitro].
Miao Y; Shen XC; Xiao CD; Wu LF; Zhou X; Tao L
Zhong Yao Cai; 2012 Oct; 35(10):1674-9. PubMed ID: 23627137
[TBL] [Abstract][Full Text] [Related]
11. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
[TBL] [Abstract][Full Text] [Related]
12. Modified emulsion solvent evaporation method for fabricating core-shell microspheres.
Xiao CD; Shen XC; Tao L
Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803
[TBL] [Abstract][Full Text] [Related]
13. Controlling the internal morphology of aqueous core-PLGA shell microcapsules: promoting the internal phase separation via alcohol addition.
Abulateefeh SR; Al-Adhami GK; Alkawareek MY; Alkilany AM
Pharm Dev Technol; 2019 Jul; 24(6):671-679. PubMed ID: 30556763
[TBL] [Abstract][Full Text] [Related]
14. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system.
Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK
J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022
[TBL] [Abstract][Full Text] [Related]
16. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
Xu H; Zhong H; Liu M; Xu C; Gao Y
Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
[TBL] [Abstract][Full Text] [Related]
17. Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.
Hong X; Wei L; Ma L; Chen Y; Liu Z; Yuan W
Int J Nanomedicine; 2013; 8():2433-41. PubMed ID: 23882140
[TBL] [Abstract][Full Text] [Related]
18. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
19. Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.
Chen W; Palazzo A; Hennink WE; Kok RJ
Mol Pharm; 2017 Feb; 14(2):459-467. PubMed ID: 27973854
[TBL] [Abstract][Full Text] [Related]
20. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
